NexImmune announced that Sol Barer, PhD has been appointed as the company’s Chairman of the Board of Directors. In January 2017, Barer & Son Capital led a consortium of private investors to acquire NexImmune, at which time he served as a Board Observer to the company. Dr. Barer is a founder and former Chairman, President, COO and CEO of Celgene. He brings more than 30 years of experience in the biotechnology industry to the NexImmune Board of Directors. Dr. Barer currently serves as Board Chair for Teva Pharmaceuticals, Centrexion Therapeutics, and Aevi Genomic Medicine.